Brian C Judkins sold $7.2M of CHE
VP and Chief Legal Officer at CHEMED CORP. 11,158 shares at an average of $645.00, traded Mar 20, 2024, filed Dec 20, 2024.
Score components
- +15RoleOfficer
- +25Trade size$7.2M at market
- +20Share of holdings soldSold 88% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-138847, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 20, 2024 | MOption exercise Capital Stock | +5,825 | $413.19 | $2.4M | 6,558 | Dec 20, 2024 |
| Mar 20, 2024 | MOption exercise Capital Stock | +6,133 | $471.74 | $2.9M | 12,691 | Dec 20, 2024 |
| Mar 20, 2024 | SOpen-market sale Capital Stock | -11,158 | $645.00 | $7.2M | 1,533 | Dec 20, 2024 |
| Mar 20, 2024 | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -5,825 | $413.19 | $2.4M | 29,183 | Dec 20, 2024 |
| Mar 20, 2024 | MOption exercise Stock Option (right to buy with tandem tax withholding)derivative | -6,133 | $471.74 | $2.9M | 23,050 | Dec 20, 2024 |
Related signals
Other insiders at CHEMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | CHEsell CHEMED CORP | Kevin J McNamara president and CEO | $1.0M 2,000 shares | -3% | |
| 50Moderate | CHEsell CHEMED CORP | Kevin J McNamara president and CEO | $1.0M 2,000 shares | -3% | |
| 44Moderate | CHEsell CHEMED CORP | Kevin J McNamara president and CEO | $554k 1,500 shares | -2% | |
| 47Moderate | CHEsell CHEMED CORP | Kevin J McNamara president and CEO | $806k 2,000 shares | -2% | |
| 48Moderate | CHEsell CHEMED CORP | Kevin J McNamara president and CEO | $875k 2,000 shares | -2% | |
| 50Moderate | CHEsell CHEMED CORP | Kevin J McNamara president and CEO | $1.4M 3,000 shares | -3% | |
| 23Weak | CHEsell CHEMED CORP | Patrick P Grace director | $70k 150 shares | -4% | |
| 68Notable | CHEMED CORP | Nicholas Michael Westfall Executive Vice President | $4.2M 10,012 shares | -100% | |
| 45Moderate | CHEbuy CHEMED CORP | George J Walsh III director | $83k 200 shares | +6% | |
| 56Moderate | CHEMED CORP | Kevin J McNamara president and CEO | $857k 2,000 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.